Iterum Therapeutics Plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CAPTRUST FINANCIAL ADVISORS | 02/17/2026 | 138.60 K | $46.43 K | 24.19% | 0.30% |
| BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC | 02/09/2026 | 66 | $22 | 0.00% | 0.00% |
| CYPRESS CAPITAL MANAGEMENT LLC (WY) | 02/09/2026 | 66 | $22 | 0.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Iterum Therapeutics Plc institutional Ownership - FAQ's
During the previous two years, 12 institutional investors and hedge funds held shares of Iterum Therapeutics Plc. The most heavily invested institutionals were:
CAPTRUST FINANCIAL ADVISORS: 138,600
BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC: 66
Cypress Capital Management LLC (WY): 66
American Portfolios Advisors: 0
QS Investors, LLC: 384,200
Hoover Financial Advisors, Inc.: 500
0.00% of Iterum Therapeutics Plc stock is owned by institutional investors.
Institutional investors have bought a total of 755.66 K shares in the last 24 months. This purchase volume represents approximately $166.25 K in transactions.